Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manoj C Desai

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Bioorganic & Medicinal Chemistry Letters|January 14, 2014
Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350)Lianhong Xu, Hongtao Liu, Allen Hong, et al.
Bioorganic & Medicinal Chemistry|January 31, 2009
Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitorsConstantine G Boojamra, Jay P Parrish, David Sperandio, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2020
Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitorsSavithri Ramurthy, Keith B Pfister, Rustum S Boyce, et al.
Bioorganic & Medicinal Chemistry|April 23, 2010
Discovery of GS-9131: Design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148Richard L Mackman, Adrian S Ray, Hon C Hui, et al.
Journal of Medicinal Chemistry|December 11, 2013
Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infectionJohn O Link, James G Taylor, Lianhong Xu, et al.
Journal of Medicinal Chemistry|October 4, 2016
Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I<sub>Na</sub>i), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic PropertiesJeff A Zablocki, Elfatih Elzein, Xiaofen Li, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Bioorganic & Medicinal Chemistry Letters|January 14, 2014
Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350)Lianhong Xu, Hongtao Liu, Allen Hong, et al.
Bioorganic & Medicinal Chemistry|January 31, 2009
Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitorsConstantine G Boojamra, Jay P Parrish, David Sperandio, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2020
Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitorsSavithri Ramurthy, Keith B Pfister, Rustum S Boyce, et al.
Bioorganic & Medicinal Chemistry|April 23, 2010
Discovery of GS-9131: Design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148Richard L Mackman, Adrian S Ray, Hon C Hui, et al.
Journal of Medicinal Chemistry|December 11, 2013
Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infectionJohn O Link, James G Taylor, Lianhong Xu, et al.
Journal of Medicinal Chemistry|October 4, 2016
Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I<sub>Na</sub>i), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic PropertiesJeff A Zablocki, Elfatih Elzein, Xiaofen Li, et al.
Pageof 2